Stem Cells and Signaling Pathways

Stem Cells and Signaling Pathways provides mechanistic insights into the role of stem cells to combat the COVID-19 outbreak and other pathologies where a cytokine storm is the cause of concern for e.g., radiation exposure, multiple organ failure and sepsis. The advent of SARS-CoV-2 resulted in a global pandemic, putting individuals with other comorbidities at a higher risk of infection. The whole world witnessed a massive shortage of medical and other essential supplies needed to combat the virus. That said, stem cell therapy has emerged as a potential treatment for viral diseases, including but not limited to COVID-19.

Interestingly, the clinical trials in the patients having COVID-19 complications depicted faster recovery in patients post mesenchymal stem cells therapy owing to the decreased cytokines levels, anti-viral effects and regeneration of the infected tissue.

• Evaluates the role of MSCs to combat cytokine storm, the challenges regarding COVID-19 therapy, and how they can be countered with the use of stem cells and the risk of opportunistic infections post COVID-19
• Presents how stem cell therapy has emerged as a potential treatment for viral diseases, including but not limited to COVID-19
• Provides a detailed understanding of the novel coronavirus, with an emphasis on the therapeutic aspects